CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,976,132 | -59.0% | 219,787 | -49.2% | 0.03% | -55.7% |
| Q2 2023 | $24,312,606 | +148.8% | 433,071 | +100.5% | 0.06% | +117.9% |
| Q1 2023 | $9,771,218 | +476.0% | 216,034 | +417.7% | 0.03% | +460.0% |
| Q4 2022 | $1,696,365 | -76.8% | 41,731 | -62.8% | 0.01% | -80.0% |
| Q3 2022 | $7,325,000 | +165.4% | 112,088 | +146.8% | 0.02% | +177.8% |
| Q2 2022 | $2,760,000 | -86.2% | 45,425 | -85.7% | 0.01% | -84.7% |
| Q1 2022 | $19,984,000 | +24.0% | 318,374 | +49.8% | 0.06% | +73.5% |
| Q4 2021 | $16,110,000 | +2630.5% | 212,584 | +3930.8% | 0.03% | +3300.0% |
| Q3 2021 | $590,000 | -99.2% | 5,274 | -98.8% | 0.00% | -99.4% |
| Q2 2021 | $69,779,000 | -49.7% | 431,025 | -62.1% | 0.16% | -56.2% |
| Q1 2021 | $138,678,000 | +222.1% | 1,138,108 | +304.7% | 0.36% | +191.1% |
| Q4 2020 | $43,060,000 | +115.9% | 281,235 | +17.9% | 0.12% | +74.6% |
| Q3 2020 | $19,949,000 | +130.7% | 238,511 | +102.7% | 0.07% | +65.1% |
| Q2 2020 | $8,646,000 | -11.1% | 117,648 | -48.7% | 0.04% | -45.6% |
| Q1 2020 | $9,728,000 | -65.2% | 229,389 | -50.0% | 0.08% | -6.0% |
| Q4 2019 | $27,956,000 | +610.3% | 459,006 | +378.0% | 0.08% | +546.2% |
| Q3 2019 | $3,936,000 | +150.2% | 96,028 | +187.5% | 0.01% | +160.0% |
| Q2 2019 | $1,573,000 | -42.3% | 33,400 | -56.2% | 0.01% | -44.4% |
| Q1 2019 | $2,726,000 | -81.3% | 76,312 | -85.0% | 0.01% | -84.2% |
| Q4 2018 | $14,558,000 | -19.4% | 509,572 | +25.2% | 0.06% | +16.3% |
| Q3 2018 | $18,055,000 | +481.5% | 407,094 | +670.4% | 0.05% | +444.4% |
| Q2 2018 | $3,105,000 | -35.2% | 52,840 | -49.6% | 0.01% | -43.8% |
| Q1 2018 | $4,790,000 | +343.9% | 104,798 | +128.0% | 0.02% | +300.0% |
| Q4 2017 | $1,079,000 | – | 45,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |